The impact of the emergence of COVID-19 on women's prenatal genetic testing decisions.


Journal

Prenatal diagnosis
ISSN: 1097-0223
Titre abrégé: Prenat Diagn
Pays: England
ID NLM: 8106540

Informations de publication

Date de publication:
07 2021
Historique:
revised: 28 12 2020
received: 10 11 2020
accepted: 10 01 2021
pubmed: 12 2 2021
medline: 6 8 2021
entrez: 11 2 2021
Statut: ppublish

Résumé

We conducted a study to examine the impact of COVID on patients' access and utilization of prenatal genetic screens and diagnostic tests at the onset of the COVID-19 pandemic in the United States. We conducted telephone interviews with 40 patients to examine how the pandemic affected prenatal genetic screening and diagnostic testing decisions during the initial months of the pandemic in the United States. An interview guide queried experiences with the ability to access information about prenatal genetic testing options and to utilize the tests when desired. Audio recordings were transcribed and coded using NVivo 12. Analysis was conducted using Grounded Theory. The pandemic did not alter most participants' decisions to undergo prenatal genetic testing. Yet, it did impact how participants viewed the risks and benefits of testing and timing of testing. There was heightened anxiety among those who underwent testing, stemming from the risk of viral exposure and the fear of being alone if pregnancy loss or fetal abnormality was identified at the time of an ultrasound-based procedure. The pandemic may impact patients' access and utilization of prenatal genetic tests. More research is needed to determine how best to meet pregnant patients' decision-making needs during this time.

Identifiants

pubmed: 33569794
doi: 10.1002/pd.5902
pmc: PMC8014673
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1009-1017

Subventions

Organisme : NHGRI NIH HHS
ID : R01 HG010092
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01HG010092
Pays : United States
Organisme : NHGRI NIH HHS
ID : R01HG010092
Pays : United States

Informations de copyright

© 2021 John Wiley & Sons Ltd.

Références

Semin Perinatol. 2020 Oct;44(6):151300
pubmed: 32928561
Qual Health Res. 2019 Jan;29(2):211-221
pubmed: 30182811
Int Nurs Rev. 2014 Dec;61(4):543-54
pubmed: 25358873
Soc Sci Med. 2007 Nov;65(10):2147-59
pubmed: 17681409
Prenat Diagn. 2020 Mar;40(4):470-480
pubmed: 31661555
Patient Educ Couns. 2021 May;104(5):1229-1236
pubmed: 33248869
Obstet Gynecol. 2019 Mar;133(3):525-532
pubmed: 30741804
Obstet Gynecol. 2016 May;127(5):e123-e137
pubmed: 26938574
J Affect Disord. 2015 Apr 1;175:385-95
pubmed: 25678171
J Affect Disord. 2019 Aug 1;255:27-40
pubmed: 31129461
Obstet Gynecol. 2009 Jan;113(1):53-63
pubmed: 19104360
Genet Med. 2016 Oct;18(10):1056-65
pubmed: 27467454
J Hosp Med. 2020 Nov;15(11):694-695
pubmed: 32853145
Genet Med. 2013 Feb;15(2):139-45
pubmed: 22955112
Matern Child Health J. 2007 Nov;11(6):595-602
pubmed: 17557201
Obstet Gynecol. 2014 Nov;124(5):987-991
pubmed: 25437728
Acta Obstet Gynecol Scand. 2020 Jul;99(7):848-855
pubmed: 32449178
Am J Perinatol. 2020 Oct;37(12):1271-1279
pubmed: 32757185
Prev Chronic Dis. 2020 Jul 23;17:E70
pubmed: 32701430
Prenat Diagn. 2021 Jul;41(8):1009-1017
pubmed: 33569794
Southeast Asian J Trop Med Public Health. 2013 May;44(3):388-99
pubmed: 24050070
Semin Perinatol. 2017 Aug;41(5):308-317
pubmed: 28625554
Curr Psychiatry Rep. 2008 Aug;10(4):331-5
pubmed: 18627672
J Midwifery Womens Health. 2010 Sep-Oct;55(5):421-9
pubmed: 20732663
J Genet Couns. 2017 Dec;26(6):1348-1356
pubmed: 28667567
Biol Psychiatry. 2012 Jul 15;72(2):113-8
pubmed: 22325982
J Patient Exp. 2018 Mar;5(1):26-33
pubmed: 29582008
Prenat Diagn. 2012 Apr;32(4):396-400
pubmed: 22467170
Public Health. 2020 Dec;189:26-36
pubmed: 33142123
Contemp Fam Ther. 2020;42(3):205-216
pubmed: 32836768
Soc Sci Med. 2012 Jun;74(12):1968-78
pubmed: 22475401

Auteurs

Ruth M Farrell (RM)

OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Center for Bioethics, Cleveland Clinic, Cleveland, Ohio, USA.

Madelyn Pierce (M)

OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Christina Collart (C)

OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Caitlin Craighead (C)

OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Marissa Coleridge (M)

OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.
Genomic Medicine Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Edward K Chien (EK)

OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Uma Perni (U)

OB/GYN and Women's Health Institute, Cleveland Clinic, Cleveland, Ohio, USA.

Richard Frankel (R)

Cleveland Clinic Lerner College of Medicine, Cleveland, Ohio, USA.

Angela Ranzini (A)

Department of OB/GYN, MetroHealth Medical Center, Cleveland, Ohio, USA.

Brownsyne Tucker Edmonds (BT)

Department of OB/GYN, Indiana University, Indianapolis, Indiana, USA.

Susannah S Rose (SS)

Center for Patient Experience, Cleveland Clinic, Cleveland, Ohio, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH